article · Endocrine Metabolic & Immune Disorders - Drug Targets

Role of Both Protein C and Antithrombin III as Predictors of Stage of Liver Disease in Chronic Viral Hepatitis B or C Infected Patients

Amany Abo-Elenein
Tamer Haydara
Mariam Zaghloul
Waseem M. Seleem
Ola M. Saeed
Heba Elashry
Samah A. Elshweikh
Mahmoud Elkadeem
Maaly Mohamed Mabrouk
Samy A. Khodeir
Sabry Abou-Saif
Sherief Abd‐Elsalam

201911 citationsKafr el-Sheikh University

Abstract

Antithrombin III and protein C are natural anticoagulants and can be considered as markers of different stages of chronic liver disease. This is supported further by the comparison between the levels of these parameters and clinical stages of liver disease. Protein C is more sensitive than ATIII as a marker of hepatocellular damage.

Research topics

Liver Disease Diagnosis and Treatment
Liver Disease and Transplantation
Hepatitis C virus research

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2174/1871530319666190529092555

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.